手机看黄色大片1024,亚洲v无码一区二区三区四区观看,黄真人在线观看高清无码,极品嫩模大尺度av在线播放免费观看

產品資料

DMS 79細胞

如果您對該產品感興趣的話,可以
產品名稱: DMS 79細胞
產品型號: DMS 79
產品展商: HZbscience
產品文檔: 無相關文檔

簡單介紹

DMS 79細胞應如何避免細胞污染,細胞污染的種類可分成**、酵母菌、霉菌、病毒和霉漿菌。主要的污染原因為無菌操作技術不當、操作室環境不佳、污染之血清和污染之細胞等。嚴格之無菌操作技術、清潔的環境、與品質良好之細胞來源和培養基配制是減低污染之*好方法。DMS 79細胞何時須更換培養基?視細胞生長密度而定,或遵照細胞株基本數據上之更換時間,按時更換培養基即可。


DMS 79細胞  的詳細介紹

DMS 79細胞

器官來源: 肺

生長狀態: 懸浮生長,多細胞聚集

ATCC Number: CRL-2049?

相關**: 小細胞肺癌

是否是腫瘤細胞: 1

物種來源: 人

年限: 65 years

運輸方式: 凍存運輸

數量: 大量

Designations: DMS 79

Depositors: OS Pettengill, G Sorenson

Biosafety Level: 1

DMS 79細胞Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: suspension, multicell aggregates

Organism: Homo sapiens

Morphology:

Source: Organ: lung

Disease: carcinoma; small cell lung cancer

Cellular Products: adrenocorticotropin (adrenocorticotropic hormone, ACTH); bombesin; calcitonin; corticotropin; beta endorphin; 17 beta estradiol; lipotropin; oxytocin - neurophysin (OT-NP); parathormone; somatostatin-like immunoreactivity (SRIF)

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Restrictions: Note: DMS 79細胞These cells are distributed subject to the following: 1.) This cell line or its products must not be distributed to third parties. Commercial interests are the exclusive property of Dartmouth College. 2.) Any proposed commercial use of these cells must first be negotiated with Office of Technology Transfer, Dartmouth College, Hanover, NH, 03755. Tel: (603) 646-3675. 3.) In all papers reporting any use of these cells, or derived products, a direct reference will be made to the original publications.

Receptors: epidermal growth factor (EGF)

Tumorigenic: Yes

Oncogene: c-myc +; N-myc +; c-raf-1 +; H-ras +; K-ras +; N-ras +; v-fes -; v-fms -

Antigen Expression: Leu 7; My23

DNA Profile (STR): Amelogenin: X,Y

CSF1PO: 10

D13S317: 11

D16S539: 12

D5S818: 10

D7S820: 9,11

THO1: 8

TPOX: 8

vWA: 18

Cytogenetic Analysis: DMS 79細胞Number of cells examined = 80; Modal Chromosome Number = 79 with a range of 65 to 84; Polyploidy Rate = 14.3%

Age: 65 years

Ethnicity: Caucasian

Comments: The line was established from cells in the pleural fluid of a patient with small cell carcinoma of the lung.

The patient had previously been treated with cytoxan, vincristine, methotrexate and radiation therapy.

The cell express HLA class I and class II antigens.

Derivative chromosomes observed at high frequency in 24 karyotyped metaphases included: der(2)t(2;?18)(q10;q10); del(3)?(pter-->p21::q10-->qter); del(6)(q13); der(10); add(11)(p15); der(14)t(14;17)(q10;q10); add(15)(p11); add(15)(p11)+; and del(17)(?q24).

Two copies of each derivative chromosome was observed in each metaphase.

Less frequent derivative chromosomes included: del(12)?(q11q21)[18/24 cells] and add(13)(p11)[10/24 cells]. Four to eight additional marker chromosomes of unknown origin were generally detected in each cell.

Cytogenetics Comments: This is a hyper-triploid human cancer cell line with a modal chromosome number of 79.

A Y chromosome was verified by QM staining and C-banding. Normal chromosomes 10, 15 and 17 were absent.

The composite karyotype consists of 65 to 84, XY, +1, -2, der(2)t(2;?18)(q10;q10)(x2); -3, del(3)?(pter-->p21::q10-->qter)x2, -4, -5, +6, del(6)(?q15)x2,+7,+8,-9,-10,-10,-10, der(10)x2, -11, add(11)(p15)x2, -12, del(12)?(q11q21)[18],

-13, +14, der(14)t(14;17)(q10;q10)x2, -15, -15,- 15, der(15)x2, -16, -17, -17, 17, del(17)x2, -18, +19, -20, +21, -22[cp24]

Propagation: DMS 79細胞ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: heat-inactivated fetal bovine serum to a final concentration of 10%.

Temperature: 37.0°C

Subculturing: Protocol: Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. Cell counts are approximate since the cells grow in aggregates.

Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended

Medium Renewal: 2 to 3 times per week

Preservation: Freeze medium: Complete growth medium, 95%; DMSO, 5%

Storage temperature: liquid nitrogen phase

Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

References: 22250: Bepler G, et al. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Oncogene 4: 45-50, 1989. PubMed: 2536917

22793: Pettengill OS, et al. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45: 906-918, 1980. PubMed: 6266631

23142: Pettengill OS, et al. Animal model for small cell carcinoma of the lung. Effect of immunosuppression and sex of mouse on tumor growth in nude athymic mice. Exp. Cell Biol. 48: 279-297, 1980. PubMed: 6249655

24389: . . Lung Cancer 4: 155-161, 1988.

滬公網安備 31011702004356號